Development of Dipeptidyl Peptidase-4 Inhibitors

Development Of Dipeptidyl Peptidase-4 Inhibitors

Dipeptidyl peptidase-4 inhibitors (DPP-4 inhibitors) are enzyme inhibitors that inhibit the enzyme dipeptidyl peptidase-4 (DPP-4) and are a potent treatment for type 2 diabetes. Inhibition of the DPP-4 enzyme prolongs and enhances the activity of incretins that play an important role in insulin secretion and blood glucose control regulation. Type 2 diabetes is a chronic metabolic disease that can be caused by pancreas β-cell dysfunction, deficiency in insulin secretion, insulin resistance and/or increased hepatic glucose production. It is one of the fastest growing health concerns in the world. Current treatments are often inefficient at sustaining glycemic control and may cause undesirable side effects, such as weight gain and episodes of hypoglycemia. Therefore, new and more effective drugs have been developed with DPP-4 inhibitors playing a significant role.

Read more about Development Of Dipeptidyl Peptidase-4 Inhibitors:  History, DPP-4 Mechanism, DPP-4 Characteristics, Discovery and Development, Pharmacology, See Also

Famous quotes containing the words development of and/or development:

    I could not undertake to form a nucleus of an institution for the development of infant minds, where none already existed. It would be too cruel.
    Henry David Thoreau (1817–1862)

    Fascism, the more it considers and observes the future and the development of humanity, quite apart from political considerations of the moment, believes neither in the possibility nor the utility of perpetual peace.
    Benito Mussolini (1883–1945)